PANDA-Regional Feasibility Study of a Smartphone Pain Management Application

Not Applicable

Completed

• Conditions: Postoperative Pain; Anesthesia, Conduction
• Interventions: Other: Panda application

• Registration Number: NCT03369392
• Lead Sponsor: University of British Columbia

Brief Summary

Despite the numerous benefits of peripheral nerve blocks (PNBs) over general anesthesia (GA) in a variety of surgical procedures, PNBs can be associated with increased post-operative pain if pain medications are not taken correctly (titrated). Unfortunately, this is a common occurrence as patients often have difficulty titrating medications in the absence of direct medical care. PANDA, a smartphone-based postoperative pain management tool, is designed to address this issue by helping patients manage their pain medications. The purpose of this study is to demonstrate the feasibility of this application in patients who are discharged after receiving PNBs. The goal is to identify areas of improvement for the application itself. It is hypothesize that PANDA will be successful in supporting patients' postoperative pain management.

Detailed Description

As above

Study Timeline

• Study First Submitted: 2017-11-28
• Study First Submitted QC: 2017-12-05
• Study Start: 2017-12-11
• Study First Posted: 2017-12-12
• Primary Completion: 2019-03-31
• Study Completion: 2019-03-31
• Status Verified: 2019-04
• Last Update Submitted: 2019-04-18
• Last Update Posted: 2019-04-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

• Undergoing ambulatory surgical procedures that require peripheral nerve blocks for which there is an anticipated post-surgical pain model
• Planned post-discharge analgesic medications including non-steroidal anti-inflammatory drugs, acetaminophen and/or opioids for at least 2 days
• ASA I-III
• Written informed consent
• Have a smartphone device at their disposal

Read More

Exclusion Criteria

• Inability or refusal to provide informed consent
• Presence of significant cognitive impairment, visual impairments, neurological injury, or psychomotor dysfunction that impairs ability to use the app
• Inability to follow study instructions and complete questionnaires in English

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Arm && Interventions

Group	Intervention	Description
Feasibility Cycle 2	Panda application	Participants use the PANDA application after modifications are made based on suggestions from participants in cycle 1.
Feasibility Cycle 1	Panda application	Participants use the initial PANDA application.
Feasibility Cycle 3	Panda application	Participants use the PANDA application after modifications are made based on suggestions from participants in cycle 1 and 2.

Primary Outcome Measures

Name	Time	Method
Feasibility of the PANDA application	2-7 days post-operatively	Measured by assessing the participants' compliance with the application in supporting ongoing pain assessments and analgesic administration.

Secondary Outcome Measures

Name	Time	Method
Identify usability issues	2-7 days post-operatively	Assessed by having participants complete a Computer Systems Usability Questionnaire (CSUQ) and a brief phone interview

Trial Locations

Locations (1)

St. Paul's Hospital; 🇨🇦 Vancouver, British Columbia, Canada